Changes in urinary albumin as a surrogate for kidney disease progression in people with type 2 diabetes.

Yoichi YokoyamaKo HanaiTomomi MoriYui YamamotoNaoshi YoshidaHidekazu MurataTomohiro ShinozakiTetsuya Babazono

Published in: Clinical and experimental nephrology (2023)

UACR changes can be a useful surrogate for kidney disease progression in people with T2D. However, when setting a decrease in UACR as the surrogate, it may be necessary to simultaneously evaluate kidney function decline.

Keyphrases